Joachim B Kunz,Andreas E Kulozik
Joachim B Kunz
Sickle cell disease and the ß-thalassemias are caused by mutations of the ß-globin gene and represent the most frequent single gene disorders worldwide. Even in European countries with a previous low frequency of these conditions the prev...
Personalized Treatment for Hematologic Diseases in Europe: An EHA Position Paper [0.03%]
欧洲血液学协会关于欧洲血液系统疾病个体化治疗的立场文件
Ulrich Jäger,Peter Kapitein,John Gribben
Ulrich Jäger
ARHGEF4 Regulates an Essential Oncogenic Program in t(12;21)-Associated Acute Lymphoblastic Leukemia [0.03%]
ARHGEF4调节与t (12; 21)相关急性淋巴细胞白血病的重要致癌程序
Clemence Virely,Luca Gasparoli,Maurizio Mangolini et al.
Clemence Virely et al.
Tom F W Wolfs,Andishe Attarbaschi,Adriana Balduzzi et al.
Tom F W Wolfs et al.
Francesca Vinchi,Steven Zebulon Vance
Francesca Vinchi
Complete Tumor Regression by Liposomal Bortezomib in a Humanized Mouse Model of Multiple Myeloma [0.03%]
人源化多发性骨髓瘤小鼠模型中脂质体硼替佐米完全消除肿瘤
Anil K Deshantri,Marcel H A M Fens,Ruud W J Ruiter et al.
Anil K Deshantri et al.
Immune-based Therapies for Hematological Malignancies: An Update by the EHA SWG on Immunotherapy of Hematological Malignancies [0.03%]
血液恶性肿瘤的免疫治疗：EHA血液恶性肿瘤免疫治疗研究组最新进展
Hermann Einsele,Javier Briones,Fabio Ciceri et al.
Hermann Einsele et al.
Roger E Schutgens
Roger E Schutgens
Cerebrospinal Fluid Penetrance of Daratumumab in Leptomeningeal Multiple Myeloma [0.03%]
达特莫单抗在脑膜多发性骨髓瘤的脑脊液穿透力研究
Marina Zajec,Kristine A Frerichs,Martijn M van Duijn et al.
Marina Zajec et al.
Limits and Applications of Genomic Analysis of Circulating Tumor DNA as a Liquid Biopsy in Asymptomatic Forms of Multiple Myeloma [0.03%]
循环肿瘤DNA基因组分析作为无症状多发性骨髓瘤液态活检的限度和应用
Martina Manzoni,Alessandra Pompa,Sonia Fabris et al.
Martina Manzoni et al.